Company Filing History:
Years Active: 2003-2011
Title: Petter Lyngstadaas: Innovator in Enamel Matrix Protein Research
Introduction
Petter Lyngstadaas is a notable inventor based in Nesoddtangen, Norway. He has made significant contributions to the field of biomedical research, particularly in the development of enamel matrix protein compositions. With a total of five patents to his name, his work focuses on modulating immune responses in mammals.
Latest Patents
Lyngstadaas's latest patents include innovative compositions aimed at treating systemic inflammatory response syndrome. One of his key inventions involves the use of an active enamel matrix substance, such as amelogenin, to create pharmaceutical compositions that can prevent or treat conditions characterized by imbalances in the immune response. These conditions may include systemic or local inflammation and autoimmune diseases. His research emphasizes the importance of addressing both systemic and post-traumatic whole-body inflammation.
Career Highlights
Throughout his career, Petter Lyngstadaas has worked with several prominent companies in the biomedical field. Notable among these are Biora Bioex AB and Institut Straumann AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for immune response modulation.
Collaborations
Lyngstadaas has collaborated with several professionals in his field, including Stina Gestrelius and Christer Andersson. These partnerships have further enhanced his research and development efforts in enamel matrix protein applications.
Conclusion
Petter Lyngstadaas stands out as an influential inventor in the realm of enamel matrix protein research. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for various immune-related conditions.